top of page

Our Directorship 

Executive Director and Chief of Research and Development
Spencer M. Robinson, PhD
Founder of the field of Applied Social Neuroscience (ASN) and the originator of Cognitive Neuroeducation (CNE), a modality enabling optimization of cognitive acuity and learning realization.
Dr. Spencer M. Robinson is a neuropsychologist specializing in cognitive science, cognitive rehabilitation and educational neuroscience. Formerly a research associate with the National Institute for Stroke and Applied Neurosciences, AUT University, Auckland, New Zealand, Dr. Robinson developed the breakthrough modality of CNE that defines the mechanisms in the human brain through which learning and cognition are formulated and applies that understanding within tailored programs that both optimize learning realization and effect recovery from a wide spectrum of cognitive and behavioral disorder.
Manolo E. Beelke

Clinical Neurophysiologist, Psychiatrist, and Biologics and Pharmacological Consultant, Germany

Dr. Beelke holds an MD from the University of Genoa, Italy, a PhD in Sleep Medicine from the University of Bologna, Italy, board certification in Clinical Neurophysiology through the University of Genoa, and board certification as a Specialist in Sleep Medicine from the Italian Society for Sleep Medicine (AIMS). Dr. Beelke’s main therapeutic expertise is in neurology, psychiatry and sleep medicine, serving as an editorial board member for 3 scientific peer-reviewed journals, authoring more than 40 peer-reviewed articles, designing more than 60 clinical trials, and providing medical guidance for more than 100 clinical trials, review of more than 500 study proposals as well as providing medical peer-review for submissions for several scientific journals, and, additionally, has chaired and spoken at numerous conferences on sleep medicine, on multiple sclerosis and on life-cycle management. Dr. Beelke has been working in clinical research and drug development for the last 24 years, including 7 years within academic research in neurology and sleep medicine. He has accumulated a series of successes in pharmaceutical companies in leading initiatives in both start-up and exploratory stages. Dr. Beelke has been recruited into several senior-executive-level roles during the course of his career to manage diverse interdisciplinary teams in successful new drug applications (NDA), biologics license applications (BLA), and drug development programs. As an independent consultant, Dr. Beelke provides leadership and responsibility for clinical development strategies, medical monitoring, investor guidance, regulatory strategy, leading-edge research studies, pharmacovigilance, worldwide label review, and health economics for full-service medical guidance in business development for pharmaceuticals and biotech, identifying new companies or compounds for acquisition, and, in the capacity of CRO (contract research organization), as a noted medical advisor, facilitating contact with potential new customers.
André Miguel Alves de Carvalho
Clinical Neuropsychologist, specializing in dementia and cognitive and physical rehabilitation in aging-related impairment, Portugal
Dr. André M. Carvalho is an Advanced Specialist in Neuropsychology and Psychogerontology certified by the Order of Portuguese Psychologists (OPP), graduating 2006 from the University Institute of Psychology, Social and Life Sciences, Lisbon (ISPA), in Applied Clinical Psychology with a focus on Cognitive Psychopathology, and earning a Master’s Degree from ISPA in Cognitive Psychopathology with a focus on Neuropsychology in 2009 and a postgraduate qualification in Continuing and Palliative Care in 2011, further earning a Master’s Degree in Neuroscience from the Faculty of Medicine, University of Lisbon, in 2019. Dr. Carvalho currently serves in the capacity of Adult Neuropsychology Assistant at Hospital Professor Doutor Fernando Fonseca (HFF), Lisbon. As a lead technician at the HFF clinical trial center for the study of degenerative brain disorders, Dr. Carvalho primarily focuses on studies in Alzheimer's disease, multiple sclerosis and movement disorders with additional experience in cerebrovascular disorders and traumatic brain injury, and concurrently serves on staff at Hospital Lusiadas Lisboa (Lisbon) as a clinical neuropsychologist for adults, focusing on cognitive rehabilitation in dementia and other neurodegenerative disorders of the elderly. Dr. Carvalho also holds the position of guest lecturer in Clinical Neuropsychology for Adults and Cognitive Rehabilitation for the Elderly at the University Institute of Psychology, Social and Life Sciences, Advanced Training Department (ISPA-DFA), a position he has held since 2014. Since 2008 Dr. Carvalho has conducted graduate training courses in Psychophysiology, Neuroscience, and Health and Quality of Life of the Elderly in Portugal and Angola. He is currently a doctoral candidate in Neuroscience at the Faculty of Medicine of the University of Lisbon in collaboration with the Cardiovascular Center Autonomic Function Laboratory in co-supervision with the Institute of Biophysics and Biomedical Engineering of the Faculty of Sciences (FCUL-IBEB). In addition to the rehabilitation of aging-related cognitive and physical impairment, Dr. Carvalho’s interests in academics and research include the autonomic nervous system and related cardiovascular physiology, information technology in digital health, and mental-health services management and development policies.
James Mbatia Kinuthia
Social Care Innovator and Healthy Aging Advocate, Kenya
A 2010 graduate in Clinical Medicine & Community Health from Kampala International University, Uganda, and certified 2016 in Geriatrics and Gerontology from the International Institute on Ageing, UN-Malta, James is a leading advocate and foremost innovator in eldercare in Kenya, pioneering long-term care residential facilities in Kenya, founding the SJ Remedial Care Home for the Elderly in 2014 and the Four Shift Home Care for the Elderly in 2016. In 2019 James was installed as the Director/Chairman of the Partners in Care Homes association, and, from 2018, has served as the Ambassador in Kenya for CommonAge, the Commonwealth Association for the Ageing.
Andrea B. Maier
Gerontologist, Geriatrician, and health policy planning authority, Australia and The Netherlands
Professor Maier, a Fellow of the Royal Australasian College of Physicians (FRACP), graduated in Medicine (MD) 2003 from Universität zu Lübeck (University of Lübeck, Germany), was registered 2009 in The Netherlands as Specialist in Internal Medicine-Geriatrics and 2013 was appointed Professor of Gerontology at Vrije Universiteit Amsterdam (VU University Amsterdam, The Netherlands). Since 2016 Professor Maier has served as Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia, and as Professor of Medicine and Aged Care at the University of Melbourne, Australia. As the Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital, Professor Maier is responsible for the daily management of non-surgical hospital and community services and implementation of novel, efficacious and cost-effective health care models. Professor Maier’s research focuses on unraveling the mechanisms of aging and the interaction of aging and age-related diseases. During the last 10 years she has conducted multiple European observational and clinical trial studies and has published some 270 peer-reviewed articles, achieving an H index of 48, spearheading the significant contributions of her highly acclaimed innovative, global, multidisciplinary @Age research group. She is a frequent guest on radio and television programs to disseminate aging research and an invited member of several international academic and health policy committees.
Harry McConnell
Physician, Clinical Neuropsychiatrist, Inclusive Community Health and Disability Advocate, Australia
Professor McConnell is a neuropsychiatrist specializing in developmental disorders and brain injury with more than 30 years of experience in both the clinical and public health aspects of health and disability. He has trained in both neurology and psychiatry as well as in disability medicine, pain medicine epileptology and psychology. He has published five textbooks and worked as Clinical Editor at BMJ Clinical Evidence (the British Medical Journal of Clinical Evidence). Professor McConnell has worked extensively with the US National Institutes of Health (NIH), the World Bank Institute (WBI), the World Health Organization (WHO), and other key national and international agencies. He trained at healthcare centers of excellence in the USA, Canada, New Zealand and the UK. Professor McConnell has also edited seminal texts concerned with synthesizing research and establishing the evidence-based practice of psychiatry, and he is the co-editor of arguably the leading texts for evidence-based practice in medicine, with major contributions to the industry-standard reference Maudsley Prescribing Guidelines and such highly regarded journals as BMJ Clinical Evidence and Evidence-Based Mental Health. In Australia he has been the Director of Neurosciences at St. Vincent's Hospital, Brisbane; Neuropsychiatrist at the Northern Brain Injury Rehabilitation Service; Clinical Sub-Dean and Professor of Neuropsychiatry and Neurodisability at Griffith University School of Medicine; Chair of the Queensland Disability Advisory Council, South East Region; Chair of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Neuropsychiatry Committee; and Director of the Institute for the Clinical Advancement of Neuroplasticity (I CAN!). Professor McConnell has also been an advisor to many ministers in various governmental departments of health and disability both at a national and state level and Expert Advisor to the Australian Therapeutic Goods Administration as well as a major contributing member of the Australian Advisory Committee on Prescription Medicines (ACPM). He has worked with regional Public Advocate offices in Australia and with key advocacy organizations for human rights and advocacy issues related to disability, being passionate about developing integrated evidence-based services for people with neurological and neuropsychiatric disorders. He has developed highly successful national referral centers in Australia and in the USA and is widely known for his commitment to integrated values-based approaches to health and disability. On the basis of his global reputation and achievements in academic medicine, clinical neuropsychiatry and public health, Professor McConnell is one of a very small handful of Queensland physicians who have been awarded MO4 (International Pre-eminence) status with Queensland Health and an even smaller handful who have been awarded International Eminence (Category III) Fellowship from RANZCP. Professor McConnell has provided consultancy to many national governments and Royal Commissions and has worked directly with heads of state and health ministers internationally. He played an instrumental role with the African Union in the development of the first Africa-wide policy on HIV, malaria, TB and other broadly spread debilitating diseases, significantly contributing to the great reduction in the incidence of those diseases in Africa over the past decades. Professor McConnell has also been involved in both volunteer and paid capacities in special education and in the Special Olympics and recreational programs for people with intellectual and neuropsychiatric disabilities. Professor McConnell is a Master Certified Medical Examiner (MCIME); a member of the American Academy of Neurology (AAN); an associate member of the Australian and New Zealand Association of Neurologists (ANZAN); a member of the European Academy of Neurology (EAN); and a Fellow of RANZCP and of the Australasian Society of Lifestyle Medicine (ASLM) as well as the Royal College of Physicians and Surgeons of Canada (RCPSC).  Professor McConnell has earned Certification with the US Boards of Pain Medicine, Medical Psychotherapy, Disability Medicine/ABIME (American Board of Independent Medical Examiners) and Psychiatry. He has been distinguished for convening two debates between the candidates running in the 2003 and 2006 election of the new WHO Director-General. He is the founder of a unique inclusive community for people with disability and their families focusing on lifestyle medicine principles in Australia as Chair of  I CAN! (the Institute for the Clinical Advancement of Neuroplasticity).
Sandra Regina Schewinsky
Neuropsychologist in Cognitive and Behavioral Rehabilitation and Specialist in Hospital Psychology, Brazil
Certified as Specialist in Hospital Psychology by the Conselho Regional de Psicologia de São Paulo (CFP – São Paulo Regional Council of Psychology), Professor Schewinsky earned her Master’s Degree in Developmental Psychology at the Universidade São Marcos (UNIMARCO – University of São Marcos) and her PhD in Social Psychology at Pontificia Universidade Católica de São Paulo (PUC SP - Pontifical Catholic University of São Paulo). Professor Schewinsky is in private practice in psychological counseling while serving in the positions of Psychologist-In-Charge at the Rehabilitation Medicine Institute of the Hospital das Clínicas (Clinical Hospital) of the University of São Paulo Medical School, Neuropsychologist at Hospital Sírio Libanês (the Syrian Lebanese Hospital), and Professor at the Núcleo de Estudios e Pesquisa em Psicologia Hospitalar (NEPPHO – the Center for Studies and Research in Hospital Psychology).
Alberto Zani
Psychologist and Neuroscientist specializing in brain-mind interaction, Italy
Professor Zani currently holds the position of Professor of General and Experimental Psychology, School of Psychology, Vita-Salute San Raffaele University, Milan, Italy. For some 25 years Professor Zani has held positions as a leading researcher in several institutes of the Consiglio Nazionale delle Ricerche (CNR – National Research Council of Italy), including: the Institute of Psychology, where he was Director of Cognitive Electrophysiology (IP-CNR); the Institute of Molecular Bioimaging and Physiology, where he was Director of the Electro-Functional Brain Imaging Unit (EFBIu) in the Cognitive Electrophysiology Lab (IBFM-CNR); and the Institute of Molecular Bioimaging and Physiology, where he was a member of the steering scientific board concerned with the investigation of the relationships between brain and mind from a cognitive neuroscience perspective. Since 2012, Professor Zani has continuously served as the Editor-in-Chief of the International Journal of Brain and Cognitive Sciences, and concurrently serves as a member of the editorial board of several scientific journals such as: Psychology and Psychiatry, Psychology and Behavioral Science International Journal, and Brain Sciences, etc. Among the five published books Professor Zani has authored, he has co-authored 3 monographs with Alice Proverbio (Milan Center for Neuroscience, University of Milano-Bicocca), entitled The Cognitive Electrophysiology of Mind and Brain (Foreword by Michael Posner), Cognitive Psychophysiology (Psicofisiologia cognitiva: i substrati neuro-funzionali della mente umana – Foreword by Michael Gazzaniga), and Instrumental Research Methods in Cognitive Neuroscience: EEG and ERP  (Metodi strumentali nelle Neuroscienze Cognitive: EEG ed ERP) – the latter two published in Italian. Professor Zani has also authored some 110 research articles in the areas of performance-related human information processing, visual attention, object perception and categorization, language, and sociorelational neurocognition in such respected peer-reviewed journals as Perceptual and Motor Skills, Trends in Cognitive Sciences, Scientific Reports - Nature, Behavioral and Brain Functions, and PLOS One. Having an extensive interest in brain and mind functions, Professor Zani investigates the localization of dynamic activations of neural networks subserving such cognitive domains as vision, visual perception, attention, and polyglotism, and more widely investigates general concepts and principles in cognitive, social and educational neuroscience.
bottom of page